[CADL] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
30-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -310.26%
YoY-
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 31 31 31 31 31 31 31 0.00%
PBT -16,162 -17,080 -4,478 -10,478 -2,554 -2,876 -1,772 335.95%
Tax 14 15 191 4,504 154 413 72 -66.40%
NP -16,162 -17,080 -4,478 -10,478 -2,554 -2,876 -1,772 335.95%
Tax Rate - - - - - - - -
Total Cost 16,193 17,111 4,509 10,509 2,585 2,907 1,803 331.49%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -52,135.48 -55,096.77 -14,445.16 -33,800.00 -8,238.71 -9,277.42 -5,716.13 335.95%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.69 -0.69 -0.24 -0.56 -0.14 -0.15 -0.09 288.32%
EPS Diluted -0.69 -0.69 -0.24 -0.56 -0.14 -0.15 -0.09 288.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.